15.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KROS Giù?
Forum
Previsione
Keros Therapeutics Inc Borsa (KROS) Ultime notizie
Is Keros Therapeutics Inc. stock poised for growth2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Quantitative breakdown of Keros Therapeutics Inc. recent moveOptions Play & Weekly Chart Analysis and Guides - newser.com
Can Keros Therapeutics Inc. recover in the next quarterMarket Performance Summary & Verified Technical Signals - newser.com
Keros Therapeutics Inc Stock Analysis and ForecastMarket Profile Overview & Double Digit Returns - earlytimes.in
Can Keros Therapeutics Inc. rally from current levelsSwing Trade & Weekly Hot Stock Watchlists - newser.com
What analysts say about Keros Therapeutics Inc stockInsider Selling Patterns & Affordable Trading Plans - earlytimes.in
Is Peeti Securities Limited Positioned to Benefit From Geographic ExpansionSector Performance Review & Achieve Triple Digit Returns - earlytimes.in
How to interpret RSI for Keros Therapeutics Inc. stockWeekly Trade Recap & AI Powered Market Entry Ideas - newser.com
Can machine learning forecast Keros Therapeutics Inc. recoveryEarnings Overview Report & Long-Term Growth Portfolio Plans - newser.com
Will Keros Therapeutics Inc. bounce back from current support2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com
What momentum indicators show for Keros Therapeutics Inc. stock2025 Analyst Calls & Trade Opportunity Analysis Reports - newser.com
Is Keros Therapeutics Inc a good long term investmentEconomic Indicators Overview & Affordable Market Investment - earlytimes.in
What drives Keros Therapeutics Inc stock priceContrarian Investment Ideas & Today’s Picks, Tomorrow’s Winners - earlytimes.in
Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting - ADVFN
Keros Therapeutics Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Assenagon Asset Management S.A. Purchases 36,360 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
Keros Therapeutics: A Potential Dart Throw (NASDAQ:KROS) - Seeking Alpha
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Is now a turning point for Keros Therapeutics Inc.Watch List & Reliable Price Breakout Alerts - newser.com
CEO Change: Whats next for National Storage Affiliates Trust stockMarket Trend Report & Weekly High Potential Stock Alerts - خودرو بانک
Layoff Watch: Is Liberty Global Ltd stock risky to hold now2025 Investor Takeaways & Entry and Exit Point Strategies - خودرو بانک
Acadian Asset Management LLC Invests $1.50 Million in Keros Therapeutics, Inc. $KROS - MarketBeat
Goldman Sachs Group Inc. Buys 205,022 Shares of Keros Therapeutics, Inc. $KROS - MarketBeat
What indicators show strength in Keros Therapeutics Inc.July 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Insider Sell: Is Fifth Third Bancorp a defensive stockWeekly Market Summary & Real-Time Stock Entry Alerts - khodrobank.com
IPO Launch: Is Keros Therapeutics Inc. stock trending bullishTrade Risk Summary & Accurate Buy Signal Alerts - khodrobank.com
Quarterly Risk: Will Keros Therapeutics Inc. benefit from rising consumer demandJuly 2025 Momentum & AI Optimized Trade Strategies - خودرو بانک
Buybacks Report: Is WF International Limited stock forming a triangle patternJuly 2025 Action & Fast Entry High Yield Tips - khodrobank.com
Keros Therapeutics, Inc. (NASDAQ:KROS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Trend Recap: Can BOWN expand into new marketsRate Hike & Expert Approved Momentum Trade Ideas - khodrobank.com
How to use Fibonacci retracement on Keros Therapeutics Inc.Quarterly Trade Report & Trade Opportunity Analysis Reports - newser.com
Is Keros Therapeutics Inc. stock trending bullishQuarterly Portfolio Review & Weekly High Return Forecasts - خودرو بانک
Aug Sentiment: Will Range Resources Corporation benefit from government policyInsider Buying & Expert Approved Momentum Ideas - خودرو بانک
Resistance Check: Is Keros Therapeutics Inc. stock good for income investorsWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
H.C. Wainwright Maintains Keros Therapeutics(KROS.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
Buyout Rumor: What is the target price for Keros Therapeutics Inc. stockJuly 2025 Chart Watch & High Win Rate Trade Tips - خودرو بانک
Acadian Asset Management LLC Takes Position in Keros Therapeutics, Inc. $KROS - Defense World
Whale Trades: Should you buy the dip on Lobo EV Technologies Ltd2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
Stock Market Recap: Can Keros Therapeutics Inc weather a recessionJuly 2025 Sentiment & Low Risk High Reward Ideas - خودرو بانک
Aug Retail: Is Keros Therapeutics Inc. on track to beat earningsJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - khodrobank.com
Buyout Rumor: What is the next catalyst for ACCSQuarterly Market Summary & AI Powered Buy/Sell Recommendations - خودرو بانک
Sarcopenia Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | TNF Pharma, Lipocine, Biophytis, ImmunoForge, Rejuvenate Biomed, Keros Therapeutics, BPGbio, Oncocross - Barchart.com
Momentum Shift: Whats the fair value of Keros Therapeutics Inc stockMarket Growth Review & Low Drawdown Investment Strategies - خودرو بانک
New Highs: Does Keros Therapeutics Inc stock reflect fundamentals2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
Volume Summary: What is the next catalyst for Keros Therapeutics IncMarket Growth Report & Risk Controlled Daily Plans - khodrobank.com
Quarterly Earnings: Is RMSGW stock showing strong momentumJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - خودرو بانک
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):